Endothelin-converting enzyme-1 is expressed on human ovarian follicles and corpora lutea of menstrual cycle and early pregnancy. 1998

S Yoshioka, and H Fujiwara, and S Yamada, and K Tatsumi, and T Nakayama, and T Higuchi, and T Inoue, and M Maeda, and S Fujii
Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Japan.

We have previously reported that membrane-bound amino- and carboxypeptidases were expressed on the human follicles and corpora lutea (CL), and we proposed that these peptidases are involved in ovarian functions, probably by regulating the extracellular peptide concentrations. In this study, we examined the expression of endothelin-converting enzyme-1 (ECE-1) on human follicles and CL, which is a membrane-bound endopeptidase and is known to convert big endothelin-1 to endothelin-1. In the preovulatory follicles, immunohistochemical study showed that ECE-1 was expressed, with moderate intensity, on the theca interna cells and weakly on the granulosa cells. In the menstrual and pregnant CL, ECE-1 was highly expressed on both large and small luteal cells, indicating that ECE-1 expression increases during luteinization. Western blotting analysis revealed that the molecular mass of the ECE-1 extracted from the menstrual CL was 130 kDa and that ECE-1 was more strongly expressed on the CL in early and midluteal phases than the CL in late luteal phases. In the isolated luteinizing granulosa cells obtained from patients undergoing in vitro fertilization, ECE-1 was immunohistochemically detected on their cell surface. The activity of ECE-1 was also detected on cultured luteinizing granulosa cells by measuring endothelin-1 production from its precursor. The activity of ECE-1 was significantly enhanced by the treatment of human CG (10 U/mL) and interleukin (IL)-1 (10 ng/mL) during 4-day culture, whereas no significant alteration was observed by IL-4 (10 ng/mL) and IL-10 (10 ng/mL) treatment. These results indicate that ECE-1 is a cell surface differentiation-related molecule of human granulosa and of theca interna cells and suggest that the expression of ECE-1 is regulated by LH/human CG and cytokines.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008597 Menstrual Cycle The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase. Endometrial Cycle,Ovarian Cycle,Cycle, Endometrial,Cycle, Menstrual,Cycle, Ovarian,Cycles, Endometrial,Cycles, Menstrual,Cycles, Ovarian,Endometrial Cycles,Menstrual Cycles,Ovarian Cycles
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D003338 Corpus Luteum The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE. Corpora Lutea,Lutea, Corpora
D005260 Female Females
D006080 Ovarian Follicle An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment (FOLLICULAR FLUID). The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS. Graafian Follicle,Atretic Follicle,Ovarian Follicles,Atretic Follicles,Follicle, Atretic,Follicle, Graafian,Follicle, Ovarian,Follicles, Atretic,Follicles, Graafian,Follicles, Ovarian,Graafian Follicles
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Yoshioka, and H Fujiwara, and S Yamada, and K Tatsumi, and T Nakayama, and T Higuchi, and T Inoue, and M Maeda, and S Fujii
February 1981, The Journal of clinical endocrinology and metabolism,
S Yoshioka, and H Fujiwara, and S Yamada, and K Tatsumi, and T Nakayama, and T Higuchi, and T Inoue, and M Maeda, and S Fujii
January 1992, Hormone research,
S Yoshioka, and H Fujiwara, and S Yamada, and K Tatsumi, and T Nakayama, and T Higuchi, and T Inoue, and M Maeda, and S Fujii
May 1987, Obstetrics and gynecology,
S Yoshioka, and H Fujiwara, and S Yamada, and K Tatsumi, and T Nakayama, and T Higuchi, and T Inoue, and M Maeda, and S Fujii
August 1986, Obstetrics and gynecology,
S Yoshioka, and H Fujiwara, and S Yamada, and K Tatsumi, and T Nakayama, and T Higuchi, and T Inoue, and M Maeda, and S Fujii
April 1998, Human reproduction (Oxford, England),
S Yoshioka, and H Fujiwara, and S Yamada, and K Tatsumi, and T Nakayama, and T Higuchi, and T Inoue, and M Maeda, and S Fujii
January 2011, Fertility and sterility,
S Yoshioka, and H Fujiwara, and S Yamada, and K Tatsumi, and T Nakayama, and T Higuchi, and T Inoue, and M Maeda, and S Fujii
May 1977, American journal of obstetrics and gynecology,
S Yoshioka, and H Fujiwara, and S Yamada, and K Tatsumi, and T Nakayama, and T Higuchi, and T Inoue, and M Maeda, and S Fujii
October 1982, Nihon Sanka Fujinka Gakkai zasshi,
S Yoshioka, and H Fujiwara, and S Yamada, and K Tatsumi, and T Nakayama, and T Higuchi, and T Inoue, and M Maeda, and S Fujii
April 2006, Fertility and sterility,
S Yoshioka, and H Fujiwara, and S Yamada, and K Tatsumi, and T Nakayama, and T Higuchi, and T Inoue, and M Maeda, and S Fujii
August 1988, Fertility and sterility,
Copied contents to your clipboard!